The decline in net interest income and net income signals margin compression and higher provision costs. Watch for further details on NIM trends, credit quality, and the closing of the healthcare restructuring which may unlock value. The stock may face near-term pressure from the weaker earnings.
Price Chart
Executive Summary
Bradesco's Q1 2026 net income fell 7.8% YoY to R$5.23B from R$5.68B, with net interest income declining 22.4% to R$17.33B from R$22.35B. EPS dropped to R$0.47 (common) and R$0.51 (preferred) from R$0.50 and R$0.56, respectively. The bank also announced a corporate restructuring to consolidate its healthcare business under Odontoprev (now Bradsaúde).
Key Facts
- Net income decreased 7.8% YoY to R$5.23B in Q1 2026 from R$5.68B in Q1 2025.
- Net interest income dropped 22.4% YoY to R$17.33B from R$22.35B.
- Basic EPS: common R$0.47 (vs R$0.50), preferred R$0.51 (vs R$0.56).
- Total loan portfolio grew 8.4% YoY to R$799.2B.
- Capital increased to R$93.77B via reserve capitalization; R$3.95B interest on equity provisioned.
- Corporate restructuring to consolidate health business under Odontoprev/Bradsaúde announced in February 2026, approved in April 2026.
Financial Impact
Net income down ~R$445M YoY; net interest income down ~R$5.0B YoY.
Risk Factors
- Further net interest margin compression due to elevated interest rates and funding costs.
- Increase in credit losses if economic conditions worsen.
- Execution risk in healthcare restructuring; potential dilution from Odontoprev share issuance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001292814-26-002867 |
| Document: 0001292814-26-002867-index-headers.html | 0001292814-26-002867 |
| Document: 0001292814-26-002867-index.html | 0001292814-26-002867 |
| Document: 0001292814-26-002867.txt | 0001292814-26-002867 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | Institutional Cluster | $2.97 $3.17 | ▲ +6.73% | ▲ +2.34% | $3.20 (+7.91%) |
May 29, 2026 18w ago | 6-K | $3.13 $3.20 | ▲ +2.36% | ▲ +1.18% | $3.20 (+2.52%) |
May 13, 2026 20w ago | 6-K | $3.16 $3.15 | ▼ −0.32% | ▼ −4.75% | $3.20 (+1.42%) |
May 7, 2026 21w ago | 6-K | $3.33 $3.28 | ▼ −1.50% | ▼ −5.33% | $3.20 (−3.75%) |
May 7, 2026 21w ago | 6-K | $3.33 $3.28 | ▲ +1.50% | ▲ +5.33% | $3.20 (+3.75%) |
May 7, 2026 21w ago | 6-K | $3.33 $3.28 | ▼ −1.50% | ▼ −5.33% | $3.20 (−3.75%) |
Apr 10, 2026 24w ago | 6-K | $3.68 $3.00 | ▼ −18.41% | ▼ −27.33% | $3.20 (−12.83%) |
Mar 30, 2026 26w ago | 6-K | $3.23 $2.98 | ▼ −7.83% | ▼ −20.21% | $3.20 (−0.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access